FGF21 and Insulin resistance: The potential of FGF21 to treat obesity and insulin resistance has prompted the pharmaceutical industry to develop a myriad of analogues and mimetics that have the same biological actions than endogenous FGF21 but improved pharmacokinetic properties (Zhang & Li, 2015; So & Leung, 2016).